Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) – Equities research analysts at B. Riley reduced their Q2 2020 EPS estimates for shares of Dicerna Pharmaceuticals in a research report issued on Wednesday, May 13th. B. Riley analyst M. Mamtani now anticipates that the biopharmaceutical company will post earnings of ($0.10) per share for the quarter, down from their […]
